Vylibra Kit
Product Images NDC 50102-235

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Vylibra (NDC 50102-235). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Afaxys Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Norgestimate-fig3 (Norgestimate Fig3)

A forest plot chart showing effect estimates (Odds Ratios/Relative Risks) with confidence intervals for various women's health studies from 2002 to 2017, comparing ever use and current use of a drug or intervention. The horizontal axis ranges from -1.5 to 2, with a reference line at 1.0.*

FDA Label Image

Chemical Structure (Norgestimate Str)

Chemical structure diagrams of the active ingredients norgestimate and ethinyl estradiol, showing their molecular configurations and labels for each compound.*

FDA Label Image

Norgestimate-fig4 (Norgestimate Fig4)

An illustration diagram depicting a vertical arrow labeled 'Fewer Pregnancies' at the top and 'More Pregnancies' at the bottom, showing contraceptive effectiveness by pregnancies per 100 women annually. It categorizes methods by effectiveness from fewer than 1 to 85 or more pregnancies, listing implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal ring with hormones, condoms, diaphragm, behavioral methods, and no birth control.*

FDA Label Image

Norgestimate-fig5 (Norgestimate Fig5)

Illustration showing a hand placing a day label strip over a VyLibra oral contraceptive tablet kit by Afaxys Pharma, LLC. The kit is divided into four weekly rows labeled Week 1 to Week 4 with corresponding dark blue and green tablet placeholders. Instructions indicate to pick the correct day label from Monday to Sunday and align it above the tablets.*

FDA Label Image

Norgestimate-fig6 (Norgestimate Fig6)

Instructional diagram showing the layout of VyLibra (norgestimate and ethinyl estradiol) tablet kit. It depicts four rows of pill indicator circles representing weeks 1 through 4. Weeks 1 to 3 have dark blue pills, while week 4 has green pills, arranged in a weekly cycle from Sunday to Saturday with a marked start point.*

FDA Label Image

Package Label-principal Display Panel (0.250 mg/0.035 mg Pouch Carton Label)

VyLibra 0.250 mg/0.035 mg tablets packaging label showing a kit containing norgestimate and ethinyl estradiol. The label indicates USP strength, blister card format with 28 tablets, and includes manufacturer information for Afaxys Pharma, LLC and Aurobindo Pharma Limited. Design features orange swirls on a white background with red text.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.